10x Genomics, Inc.
NASDAQ:TXG
8.77 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -182.627 | -255.099 | -166 | -58.223 | -542.731 | -31.251 | -112.485 | -18.762 |
| Depreciation & Amortization
| 43.708 | 43.619 | 33.006 | 28.254 | 19.021 | 7.066 | 3.905 | 4.305 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 1.55 | 0.614 | 0.251 | 0 |
| Stock Based Compensation
| 140.749 | 166.95 | 136.848 | 95.962 | 48.626 | 13.333 | 2.658 | 1.661 |
| Change In Working Capital
| 1.254 | 17.343 | -39.417 | -87.445 | -50.381 | 44.764 | 28.015 | 1.948 |
| Accounts Receivables
| 26.951 | -10.613 | -18.948 | -34.041 | -17.847 | -5.284 | -14.747 | -5.131 |
| Inventory
| -9.777 | 7.871 | -21.192 | -30.132 | -14.601 | -6.699 | -3.732 | -1.995 |
| Accounts Payables
| -3.354 | -6.017 | 5.858 | 11.084 | -7.77 | 4.901 | 2.587 | 3.034 |
| Other Working Capital
| -12.566 | 26.102 | -5.135 | -34.356 | -10.163 | 51.846 | 43.907 | 6.04 |
| Other Non Cash Items
| 3.58 | 11.99 | 1.957 | 0.079 | 306.017 | 0.101 | 1.247 | 0.149 |
| Operating Cash Flow
| 6.664 | -15.197 | -33.606 | -21.373 | -217.898 | 34.627 | -76.409 | -10.699 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -12.393 | -48.601 | -131.661 | -101.278 | -38.394 | -42.767 | -6.709 | -3.756 |
| Acquisitions Net
| 0 | 0 | -4 | -5.451 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -48.876 | 0 | -282.871 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 29.638 | 183.016 | 67.645 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -1 | -0.923 | -215.226 | 0 | -1.728 | -0.025 | -0.425 | 0 |
| Investing Cash Flow
| -32.631 | 133.492 | -350.887 | -106.729 | -38.394 | -42.767 | -6.709 | -3.756 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -37.104 | 0 | 18.739 | -0.393 |
| Common Stock Issued
| 0 | 19.483 | 21.226 | 40.325 | 482.267 | 410.824 | 1.798 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.08 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 10.914 | 13.669 | 15.817 | 35.297 | 23.743 | 3.766 | 86.628 | 21.056 |
| Financing Cash Flow
| 10.914 | 13.669 | 15.817 | 35.297 | 468.906 | 414.59 | 105.367 | 20.583 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0.164 | -0.033 | -0.044 | 0.234 | -0.463 | -0.045 | -0.018 | -0.014 |
| Net Change In Cash
| -15.217 | 131.931 | -368.72 | -92.571 | 212.151 | 406.405 | 22.231 | 6.114 |
| Cash At End Of Period
| 344.067 | 359.284 | 227.353 | 596.073 | 688.644 | 476.493 | 70.088 | 47.857 |